237 related articles for article (PubMed ID: 32859387)
1. Growth hormone treatment for Prader-Willi syndrome: A review.
Yang X
Neuropeptides; 2020 Oct; 83():102084. PubMed ID: 32859387
[TBL] [Abstract][Full Text] [Related]
2. The behavioral impact of growth hormone treatment for children and adolescents with Prader-Willi syndrome: a 2-year, controlled study.
Whitman BY; Myers S; Carrel A; Allen D
Pediatrics; 2002 Feb; 109(2):E35. PubMed ID: 11826245
[TBL] [Abstract][Full Text] [Related]
3. Cognitive, emotional, physical and social effects of growth hormone treatment in adults with Prader-Willi syndrome.
Höybye C; Thorén M; Böhm B
J Intellect Disabil Res; 2005 Apr; 49(Pt 4):245-52. PubMed ID: 15816811
[TBL] [Abstract][Full Text] [Related]
4. Endocrine and metabolic aspects of adult Prader-Willi syndrome with special emphasis on the effect of growth hormone treatment.
Höybye C
Growth Horm IGF Res; 2004 Feb; 14(1):1-15. PubMed ID: 14700552
[TBL] [Abstract][Full Text] [Related]
5. What is the value of growth hormone therapy in Prader Willi syndrome?
Bridges N
Arch Dis Child; 2014 Feb; 99(2):166-70. PubMed ID: 24162007
[TBL] [Abstract][Full Text] [Related]
6. Effects of recombinant human growth hormone treatment on growth, body composition, and safety in infants or toddlers with Prader-Willi syndrome: a randomized, active-controlled trial.
Yang A; Choi JH; Sohn YB; Eom Y; Lee J; Yoo HW; Jin DK
Orphanet J Rare Dis; 2019 Sep; 14(1):216. PubMed ID: 31511031
[TBL] [Abstract][Full Text] [Related]
7. Response to growth hormone treatment in Prader-Willi syndrome: auxological criteria versus genetic diagnosis.
Scheermeyer E; Hughes I; Harris M; Ambler G; Crock P; Verge CF; Craig ME; Bergman P; Werther G; van Driel M; Davies PS; Choong CS
J Paediatr Child Health; 2013 Dec; 49(12):1045-51. PubMed ID: 23781979
[TBL] [Abstract][Full Text] [Related]
8. Growth hormone treatment in adults with Prader-Willi syndrome: the Scandinavian study.
Sode-Carlsen R; Farholt S; Rabben KF; Bollerslev J; Schreiner T; Jurik AG; Christiansen JS; Höybye C
Endocrine; 2012 Apr; 41(2):191-9. PubMed ID: 22081257
[TBL] [Abstract][Full Text] [Related]
9. Prader-Willi syndrome and growth hormone deficiency.
Aycan Z; Baş VN
J Clin Res Pediatr Endocrinol; 2014; 6(2):62-7. PubMed ID: 24932597
[TBL] [Abstract][Full Text] [Related]
10. Time for a general approval of growth hormone treatment in adults with Prader-Willi syndrome.
Höybye C; Holland AJ; Driscoll DJ;
Orphanet J Rare Dis; 2021 Feb; 16(1):69. PubMed ID: 33557878
[TBL] [Abstract][Full Text] [Related]
11. Early psychomotor development and growth hormone therapy in children with Prader-Willi syndrome: a review.
Jin YY; Luo FH
Eur J Pediatr; 2024 Mar; 183(3):1021-1036. PubMed ID: 37987848
[TBL] [Abstract][Full Text] [Related]
12. Dietary Energy Intake, Body Composition and Resting Energy Expenditure in Prepubertal Children with Prader-Willi Syndrome before and during Growth Hormone Treatment: A Randomized Controlled Trial.
Bakker NE; Siemensma EP; Koopman C; Hokken-Koelega AC
Horm Res Paediatr; 2015; 83(5):321-31. PubMed ID: 25764996
[TBL] [Abstract][Full Text] [Related]
13. Sustained benefits of growth hormone on body composition, fat utilization, physical strength and agility, and growth in Prader-Willi syndrome are dose-dependent.
Carrel AL; Myers SE; Whitman BY; Allen DB
J Pediatr Endocrinol Metab; 2001; 14(8):1097-105. PubMed ID: 11592566
[TBL] [Abstract][Full Text] [Related]
14. Growth hormone therapy for Prader-Willi syndrome: a critical appraisal.
Allen DB; Carrel AL
J Pediatr Endocrinol Metab; 2004 Sep; 17 Suppl 4():1297-306. PubMed ID: 15506076
[TBL] [Abstract][Full Text] [Related]
15. Growth hormone treatment of Prader-Willi syndrome has long-term, positive effects on body composition.
Höybye C
Acta Paediatr; 2015 Apr; 104(4):422-7. PubMed ID: 25557351
[TBL] [Abstract][Full Text] [Related]
16. Randomized controlled GH trial: effects on anthropometry, body composition and body proportions in a large group of children with Prader-Willi syndrome.
Festen DA; de Lind van Wijngaarden R; van Eekelen M; Otten BJ; Wit JM; Duivenvoorden HJ; Hokken-Koelega AC
Clin Endocrinol (Oxf); 2008 Sep; 69(3):443-51. PubMed ID: 18363884
[TBL] [Abstract][Full Text] [Related]
17. Growth hormone improves body composition and motor development in infants with Prader-Willi syndrome after six months.
Whitman B; Carrel A; Bekx T; Weber C; Allen D; Myers S
J Pediatr Endocrinol Metab; 2004 Apr; 17(4):591-600. PubMed ID: 15198290
[TBL] [Abstract][Full Text] [Related]
18. Growth Hormone Treatment for Adults With Prader-Willi Syndrome: A Meta-Analysis.
Rosenberg AGW; Passone CGB; Pellikaan K; Damiani D; van der Lely AJ; Polak M; Bernardo WM; de Graaff LCG
J Clin Endocrinol Metab; 2021 Sep; 106(10):3068-3091. PubMed ID: 34105729
[TBL] [Abstract][Full Text] [Related]
19. Beneficial Effect of Growth Hormone Treatment on Health-Related Quality of Life in Children with Prader-Willi Syndrome: A Randomized Controlled Trial and Longitudinal Study.
Bakker NE; Siemensma EP; van Rijn M; Festen DA; Hokken-Koelega AC
Horm Res Paediatr; 2015; 84(4):231-9. PubMed ID: 26279206
[TBL] [Abstract][Full Text] [Related]
20. Sustained benefit after 2 years of growth hormone on body composition, fat utilization, physical strength and agility, and growth in Prader-Willi syndrome.
Myers SE; Carrel AL; Whitman BY; Allen DB
J Pediatr; 2000 Jul; 137(1):42-9. PubMed ID: 10891820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
